Controversy exists over the rapidity of onset of the inotropic effect of various digitalis glycosides. Shortening of the systolic time intervals (STI) provides a quantitative measure of the inotropic effect of digitalis glycosides in human subjects. Total electromechanical systole corrected for heart rate (QS2I) is the most sensitive of the STI since it combines the shortening effect of digitalis glycosides on both the pre-ejection period and ejection time. Normal volunteer subjects were studied serially following i.v. injection of 1.6 mg cedilanid-D (C) (n = 18), 1.0 mg ouabain (0) (n = 12), 1.6 mg digoxin (D) (n = 16), and 1.6 mg digitoxin (DT) (n =9). The shortening of QS2I was corrected for the molecular weight of the digitalis glycoside. The onset of shortening of the QS2I/mole proved to be exponential for each digitalis glycoside. This allowed estimation of the maximum shortening of QS2I/mole (A) which would occur assuming zero excretion, from which the time constant (tQ) of the curves could be determined. There was no significant difference in A among the digitalis glycosides. The t, were 5.8 min (0), 7.2 min (C), 23 min (D), and 56 min (DT). These t, were significantly different except for 0 and C. Thus both C and 0 have a rapid onset of activity which is significantly shorter than either D or DT.
difference in A among the digitalis glycosides. The t, were 5.8 min (0), 7.2 min (C), 23 min (D), and 56 min (DT). These t, were significantly different except for 0 and C. Thus both C and 0 have a rapid onset of activity which is significantly shorter than either D or DT.
The t. for C in patients with congestive heart failure is the same as normals. This study provides a heretofore unavailable, accurate measure of the differences among commonly used glycosides.
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Time constant Congestive heart failure DESPITE THEIR COMMON USE in patients with cardiovascular disease, precise data regarding the relative onset and magnitude of the positive inotropic effect of the various commonly employed digitalis glycosides are not available. In large part this reflects the fact that an easily applied measure of the contractile response to these agents has not been available. In the past, slowing of the heart rate in patients with atrial fibrillation of atrioventricular conduction disease, the rapidity of the initial heart rate, and level of adrenergic activity may influence the response of the heart rate to digitalis in atrial fibrillation. Thus studies in which slowing of atrial fibrillation is used as an end point of digitalis effect have shown wide variation in the range of response to various glycosides.
Recently the response of the systolic time intervals has been employed to provide a quantitative measurement of the positive inotropic effect of digitalis.'1-1'7 Earlier studies employed shortening of the left ventricular ejection time index (LVETI) as a measure of the response to digitalis. More recent observations indicate that total electromechanical systole corrected for heart rate (QS2I) is preferable to the LVETI.'7 The magnitude of the response of the QS21 is nearly double that of the LVETI, since both the LVETI and pre-ejection period index (PEPI) are shortened by inotropic agents in normal subjects. Furthermore, unlike the PEPI and LVETI, the QS2I provides a better measure of 517 the presence of positive inotropic effect in abnormal subjects. This is true because the repsonse of the PEPI and LVETI in abnormal subjects is also conditioned by the hemodynamic effect of the drug. 14 The present study was undertaken to compare the relative onset and magnitude of positive inotropic effect of five commonly employed digitalis glycosides in normal subjects employing the change in the QS2I as the primary measurement of the contractile response. Material The number of subjects studied and the doses employed are listed in table 1. In order to compare the maximum response to each glycoside, the dose of each glycoside was corrected for the molecular weight and the QS2I was divided by the molar dose (table 1). Figure 1 demonstrates the relationship between the heart rate and the QS2 in normal subjects before and at various times after administration of cedilanid-D. The QS2 values are shorter after cedilanid-D but the slope of the regression line is unchanged. Thus the underlying influence of heart rate upon the QS2 was unchanged by cedilanid-D. Consequently all QS2 values were corrected for heart rate using the baseline regression equations of Weissler et al. 18 The corrected value is termed the QS2I and provides a measure of the shortening of systole induced by digitalis.
The mathematical and statistical methods employed in this study were derived from techniques employed in pharmacokinetic studies and will be briefly out- lined.* 19, 20 Empirically the relationship of change in the QS2I/mole with time following administration of various digitalis glycosides appeared to be a first order or exponential relationship. Results Figure 4 shows the mean QS2I/mole versus time for the five drugs employed. Acetyl strophanthidin has an extremely rapid onset of activity and its effect is dissipated within one hour. Cedilanid-D and ouabain have a rapid onset and full effect is reached by 30 min. Digitoxin has a slower onset of activity and does not reach peak effect by one hour while both the onset of activity and peak effect of digoxin lies between those of ouabain and digitoxin. In addition, the curves appear to be similar to the theoretic curves in figure 3 in which A values are constant but time constants differ.
The least square regressions of the mean data employing a first order exponential model produced correlation coefficients of 0.99 or greater in all cases. In the case of ouabain where only two data points were available, which is the minimum number acceptable for analysis, the results are statistically consistent with those obtained for the other drugs. Thus assumption of a first order model appears suitable for analysis of the onset of inotropic activity of digitalis glycosides. Figure 5 shows the data transformed for regression as discussed earlier.
The constants A and t, and their standard deviation estimates were determined for each drug and are summarized in table 2. The maximum theoretical effect A showed no significant differences These studies were performed in normal subjects. However, in a recent study it was demonstrated that in patients with congestive heart failure the onset and magnitude of the positive inotropic effect of cedilanid-D is similar to that observed in normal subjects.14 From this data a time constant of 9 min was calculated for cedilanid-D in patients with heart failure, a value which is not stastically different from normal subjects. *We have been unable to determine the basis for this assumption as no studies of the effects of deslanoside in atrial fibrillation are available. 
